C-reactive protein
Magnesium oxide → C-reactive protein
Magnesium oxide → C-reactive protein
Evidence profile
Key finding
Magnesium supplementation significantly reduced FPG.
This study investigated the effects of magnesium oxide supplementation on glycemic control in older adults with pre-diabetes and hypomagnesemia, finding a significant reduction in fasting plasma glucose.
Evidence strength
Moderate confidence
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Quick read
The essential study design details in one scan.
Population
Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes
Intervention
Magnesium oxide
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Primary outcome
Fasting Plasma Glucose (FPG)
Comparator
Placebo Group
Plain-language summary
A plain-language read of the study's main message and where it applies.
Study focus
This study investigated the effects of magnesium oxide supplementation on glycemic control in older adults with pre-diabetes and hypomagnesemia, finding a significant reduction in fasting plasma glucose.
Improving glycemic control in older adults with pre-diabetes is crucial to prevent the progression to type 2 diabetes. This study suggests that magnesium supplementation could be a simple and effective strategy to lower fasting plasma glucose, potentially aiding in diabetes prevention efforts.
The study did not find significant changes in several key glycemic markers. The sample size and characteristics may limit generalizability. The effects on long-term diabetes outcomes remain unclear.
Published in
Publication details and source links for this paper.
Jingxin Y, Huidi Z, Yuting L, et al. Magnesium Supplementation Improves Glycemic Control in Older Adults with Pre-Diabetes and Hypomagnesemia. Frontiers in Nutrition. 2026;13:1765308. doi:10.3389/fnut.2026.1765308
Save this study and add notes to your research library.
Magnesium supplementation significantly reduced fasting plasma glucose by -0.497 mmol/L (p=0.003).
No significant differences were observed for insulin levels.
The reduction in insulin resistance favored the magnesium group but was not statistically significant.
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Magnesium oxide and C-reactive protein, Fasting Plasma Glucose (FPG), Glycated albumin, and 4 more.
This study contributes evidence to
Primary intervention
Magnesium oxide
Primary outcomes
Primary intervention
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
3
Related topics
7
Evidence pairs
298
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Core evidence
The primary outcomes reported in this study.
Magnesium oxide → C-reactive protein
Magnesium oxide → C-reactive protein
Evidence profile
Magnesium oxide → Fasting Plasma Glucose (FPG)
Magnesium oxide → Fasting Plasma Glucose (FPG)
Evidence profile
Magnesium oxide → Glycated albumin
Magnesium oxide → Glycated albumin
Evidence profile
Magnesium oxide → HbA1c
Magnesium oxide → HbA1c
Evidence profile
Magnesium oxide → Insulin
Magnesium oxide → Insulin
Evidence profile
Magnesium oxide → Insulin resistance
Magnesium oxide → Insulin resistance
Evidence profile
Magnesium oxide → Interleukin-6 (IL-6)
Magnesium oxide → Interleukin-6 (IL-6)
Evidence profile
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Magnesium Supplements and Fasting Glucose.
This study contributes to the evidence on the following intervention-outcome relationships.
Curated evidence collections and hubs this study is part of.
All studies measuring Fasting Glucose
Measures Fasting Glucose as a key outcome.
All studies on Magnesium Supplements
Contributes to Magnesium Supplements evidence base.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in the evidence archive.
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Magnesium Supplements appears to improve Fasting Glucose.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Fasting Plasma Glucose (FPG)
EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Magnesium Supplements for Insulin Resistance.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Insulin
EvidenceScore™ Limited | EvidenceScore™ 34.2 | neutral | ConsensusScore™ Unclear | 1 study
Insulin resistance
EvidenceScore™ Limited | EvidenceScore™ 34.2 | neutral | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Magnesium Supplements for HbA1c.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
HbA1c
EvidenceScore™ Limited | EvidenceScore™ 34.2 | neutral | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Magnesium Supplements for Inflammatory Markers.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
C-reactive protein
EvidenceScore™ Limited | EvidenceScore™ 34.2 | neutral | ConsensusScore™ Unclear | 1 study
Interleukin-6 (IL-6)
EvidenceScore™ Limited | EvidenceScore™ 34.2 | neutral | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.
Limitations
Next steps
Choose a next path through related evidence topics, archive views, and research summaries.
Follow the topics this study contributes to.
Open broader archive views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.